
Cocrystal Pharma COCP
€ 1.00
2.7%
Quartalsbericht 2026-Q1
hinzugefügt 15.05.2026
Cocrystal Pharma P/CF 2011-2026 | COCP
P/CF Jährlich Cocrystal Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.39 | -0.876 | -0.921 | -0.703 | -0.324 | -9.43 | -10.3 | -9.66 | -17.4 | -18.7 | -36.1 | -24.5 | -9.36 | -126 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.324 | -126 | -19 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-1.79 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
-1.63 | $ 1.73 | 5.18 % | $ 203 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Celldex Therapeutics
CLDX
|
-9.67 | $ 31.65 | 2.59 % | $ 2.1 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
48.3 | $ 94.81 | 2.78 % | $ 22.9 B | ||
|
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B | ||
|
CRISPR Therapeutics AG
CRSP
|
-12.7 | $ 53.52 | 3.74 % | $ 4.81 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-30.2 | - | 0.74 % | $ 768 M | ||
|
Compugen Ltd.
CGEN
|
6.2 | $ 2.68 | 1.13 % | $ 250 M | ||
|
Abcam plc
ABCM
|
172 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-117 | - | -18.52 % | $ 27.3 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-4.21 | $ 0.78 | 14.04 % | $ 35.6 M | ||
|
Esperion Therapeutics
ESPR
|
-42.9 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
53.1 | $ 31.66 | 1.18 % | $ 852 M | ||
|
Affimed N.V.
AFMD
|
-6.09 | - | -34.95 % | $ 21.5 M | ||
|
Forte Biosciences
FBRX
|
-6.59 | $ 22.13 | 0.87 % | $ 287 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-0.379 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | ||
|
Galectin Therapeutics
GALT
|
-7.47 | $ 2.72 | -2.69 % | $ 174 M | ||
|
Generation Bio Co.
GBIO
|
-3.39 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.195 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-2.88 | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Grifols, S.A.
GRFS
|
5.01 | $ 8.08 | 0.9 % | $ 5.49 B | ||
|
Hutchison China MediTech Limited
HCM
|
-186 | $ 11.72 | -0.26 % | $ 10.1 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-3.33 | - | - | $ 384 M | ||
|
Heron Therapeutics
HRTX
|
-7.19 | $ 0.9 | 2.13 % | $ 150 M | ||
|
Gracell Biotechnologies
GRCL
|
-6.52 | - | - | $ 3.37 B | ||
|
Anika Therapeutics
ANIK
|
19.1 | $ 14.76 | -0.87 % | $ 212 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | ||
|
InflaRx N.V.
IFRX
|
-1.79 | $ 2.6 | -5.11 % | $ 175 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.205 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.35 | -4.83 % | $ 5.51 M |